Clinical Scorecard: Key Predictors of Mild Cognitive Impairment in Type 2 Diabetes Mellitus and Their Interacting Mechanisms: A Narrative Review from a Network Analysis Perspective

At a Glance

Key Highlights

• T2DM patients have a 1.5-fold higher risk of developing MCI compared to non-diabetics.
• MCI is an intermediate state between normal aging and dementia.
• Identification of sentinel factors can provide early warning for MCI onset.
• Network analysis offers a novel approach to understanding complex interactions among risk factors.
• Early intervention is crucial to delay cognitive decline in T2DM patients.

Guideline-Based Recommendations

Diagnosis

• Utilize network analysis to identify core regulatory nodes associated with MCI.

Management

• Implement targeted interventions based on identified sentinel factors.

Monitoring & Follow-up

• Regularly assess sentinel factors through non-invasive clinical means.

Risks

• Prolonged disease duration and aging significantly increase MCI risk.

Patient & Prescribing Data

Individuals diagnosed with Type 2 Diabetes Mellitus.

Focus on modifiable risk factors to alter MCI progression.

Clinical Best Practices

• Early identification of high-risk individuals for MCI.
• Use of comprehensive evidence synthesis for targeted interventions.
• Integration of network analysis in clinical research for better understanding of risk factors.

References

• International Diabetes Federation